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We compared hemostatic changes during OLT and HLT after various periods of graft storage, to
investigate whether the host liver in HLT protects the recipient from hemostatic deterioration induced
by severe graft storage damage. In particular, the mechanism of fibrinolytic deterioration was
investigated. The effect of prostaglandin E1 (PGE1) on these parameters was also studied.
Material and Methods: 69 pigs underwent either OLT (N 32) or HLT (N 37) with a graft stored for
2 hr (N 31), 24 hr (N 16), 48 hr (N 7), or 72 hr (N 15). PGE1 was given intravenously to both
donor and recipient animals and was added to the preservation and flushing solutions. Fibrinolysis
(euglobulin clot lysis time, t-PA activity and a2-antiplasmin) and coagulation parameters (activated
partial thromboplasmin time, prothrombin time, fibrinogen and platelet count) were measured at
several intervals during transplantation.
Statistics: Univariate non-parametric tests were used for analysis of coagulation and fibrinolysis
parameters. For the three main variables- i.e., the type of transplantation, the use of PGE1, and the
preservation time, multiple regression analysis was performed.
Results: Fibrinolytic activity increased during the anhepatic period of OLT. Graft reperfusion was
followed by a rise in t-PA in both OLT and HLT. In HLT, t-PA quickly returned to normal, whereas a
continuous increase was found in OLT. The coagulation parameters, in turn, remained unchanged
during the anhepatic period and deteriorated in OLT compared to HLT. The duration of graft storage
was directly related to the severity of the hemostatic changes, although this effect was more apparent in
OLT than in HLT.
Conclusions: Changes in hemostasis are more pronounced in OLT than in HLT. This suggests that the
host liver protects the recipient from the effects of graft storage damage, even after long preservation
times. Early postreperfusion fibrinolytic activity was presumably due to t-PA release from the graft both
in OLT and HLT. The further rise t-PA in OLT might be caused by the release of cytokines from the
graft, that subsequently evoke endothelial t-PA release. In HLT, t-PA and cytokines may be cleared by
the native liver. No positive or negative effect of PGE1 on coagulation or fibrinolysis parameters was
noticed.
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INTRODUCTION
Orthotopic liver transplantation (OLT) has become an accepted method to treat
patients with end-stage chronic liver disease. However, the procedure is frequently
complicated by severe changes in hemostasis. Both increased fibrinolysis1’2 and
disseminated intravascular coagulation3’4’ have been implicated in playing a role.
The most striking abnormalities occur late in the anhepatic period and become
more marked after reperfusion of the graft5’6. Earlier studies have demonstrated
that the severity and duration of hemostasis abnormalities were mainly related to
the quality of the donor liver7’S.Release of activated hemostasis factors and/or
humoral substances from the graft, that may interfere with hemostasis have been
suggested to play a role.
Auxiliary heterotopic liver transplantation (HLT) has been proposed as an
alternative to hepatic replacement. In HLT, the host liver is left in situ and the graft
is transplanted in a heterotopic position. The anhepatic period is avoided and the
function of the host liver retained. Hence, substances released from the allograft at
reperfusion might be cleared and the deterioration of hemostasis less severe.
Recently, we demonstrated that changes in fibrinolysis after reperfusion and more
severe and substained in OLT than in HLT after 2 hours of simple cold graft
storage9. This suggested that the native liver in HLT protects the recipient from the
changes induced by preservation damage. We were now interested in whether the
host liver in HLT also protects the recipient from the effects of long-term preserved
grafts as well as the mechanism of hemostatic deterioration. We have thereby
concentrated on fibrinolysis and included, additionally to previous studies, t-PA
activity measurement.
Graft protection by addition of prostagtandin E1 (PGE1) to the flush solution has
been demonstrated in human liver transplantation1. Furthermore, successful liver
transplantations have been reported after long-term simple cold storage with
University of Wisconsin (UW) solution without addition of prostaglandins" for 24
hours and more in man11 and for 48 hours in dogsl2.It is not known if cytoprotective
agents give additional protection. Therefore we also studied the effects on hemos-
tasis of adding of PGE1 to the preservation fluid.
METHODS
Sixty-nine female Yorkshire pigs were randomly allocated to OLT (N 32) or
HLT (N 37). Thirty-one grafts were transplanted after 2 hr of cold storage, 16
after 24 hr, 7 after 48 hr and 15 after 72 hr. In the 2-hr experiments, Eurocollins’
solution was used for graft storage because UW solution was not yet available. In
the long-term preservation experiments (24-hr, 48-hr, and 72-hr), UW solution was
used. Sixteen transplantations in the different preservation groups were performed
using PGE (Table 1). Body weights of the donor and recipient animals were
similar, about 25 Kg. Histocompatibility was matched by the mixed lymphocyte
culture-test13.
Surgical Technique
Donor and recipient operations were performed as described earlier14. In OLT, a
venovenous heparin-coated iliacoportajugular bypass was introduced15.LONG-TERM GRAFT PRESERVATION 267
Table 1 Number of animals in the various preservation groups
Experimental Group Total
2 hr 24 hr 48 hr 72 hr
OLT HLT OLT HLT OLT HLT OLT HLT
PGE,+ 0 0 4 4 2 4
PGE, 16 15 4 4 3 5 5
Total 16 15 8 8 2 5 6 9
aDuration of liver preservation.
16
53
69
Blood loss was estimated from the amount of liquid sucked away from the
surgical field and collected in Buleaux bottles during the transplantation.
Depending on the amount of blood loss, 500-1000 ml donor blood was given to the
recipient. Usually, this was necessary around 30 minutes after graft reperfusion.
Anesthetic techniques were the same for all animals.
Prostaglandin
When PGE1 was given, this was started 60 min before donor hepatectomy by an
intravenous infusion rate of 100 ng/kg/min16. In addition, 1 mg/L PGE1 was added
to theUW solution1. The recipient animal was treated with a similar infusion as the
donor, starting about 60 min before the recirculation of the graft. Before implan-
tation, the graft was rinsed via the portal vein with two liters of cold (4 C) 0.9%
saline to which 1 mg/L PGE1 was added. PGE1 was supplied by The Upjohn
Company, The Netherlands.
Blood Samples
For comparison, the moments of measurement were synchronized, relative to the
moment of recirculation. Blood samples were drawn around every important
operative step (Table 2) to assess hemoglobin levels, platelet counts, and various
hemostasis parameters. Additionally, on reperfusion, the first 30 ml of perfusate
were drawn from the infrahepatic vena cava of the graft. These first hepatic outflow
samples (FR) after reperfusion were also subjected to hemostasis studies.
In OLT, R-5 is a measurement in the anhepatic phase. In HLT, there is no real
anhepatic phase, but during the portal vein anastomosis there is a period of partial
clamping of the portal vein. In the pig this often implies (almost) complete
clamping.
Table 2 Intraoperative moments of hemostatic measurements
R-60
R-5
FR
R+5
R+30
R +60
R+90
Starting value: _
hr before recirculation.
Anhepatic phase: +_ 5 min before recirculation.
First hepatic outflow after reperfusion.
+_ 5 min after recirculation.
+__ 30 min after recirculation (during the construction of the arterial anastomosis).
+_ 60 min after recirculation (5 min after the aorta anastomosis). ___
90 min after recirculation (closure).268 C. MINKE BAKKER ET AL.
Blood samples (20 ml) were taken from an arterial line. Eighteen ml of blood was
divided equally into two polystyrene test tubes, containing i ml ice-cold trisodium
citrate 0.11 mol/1 and immediately placed on melting ice. Plasma was collected after
centrifugation (2800 g, 4 C, 20 min), snap-frozen and stored in small aliquots at
-70 C until used. Two ml blood was also collected into 0.045 ml 15% sol 6.75 mg
EDTA.
A normal plasma pool was prepared rom equal volume samples obtained from
10 animals immediately after induction of anaesthesia. This pool was defined as
having 100% o normal coagulation and fibrinolysis proteins.
Hemostasis Studies
Tissue-type plasminogen activator (t-PA) was assayed according to Verheijen et
al. 17 using plasminogen, t-PA stimulator and S-2251 (from Kabi Diagnostica,
Woerden, The Netherlands) and anti (porcine-heart) t-PA immunoglobulin (from
Biopool AB, Umea, Sweden). To determine the euglobulin clot lysis time (ECLT),
standard euglobulin fractions of plasma were prepared at pH 5.9 with a plasma
dilution of 1:10TM. Precipitates were redissolved in Tris/Tween buffer (0.1 M
Tris/HCl, containing 0.1% Tween 80 [v/v] pH 7.5) and to 0.2 ml aliquots of the
dissolved euglobulin fractions 0.1 ml portions of calcium-thrombin solution (CaCI2
25 mmol/1 and thrombin 10 NIH U/I) were added to induce clot formation. The lysis
time of the clot was recorded. The disappearance of air bubbles was regarded as the
endpoint of lysis, a2-Antiplasmin (tz2-AP) activity was measured according to
Friberger et al.
19 using Coatest, antiplasmin (Kabi Diagnostica, Woerden, The
Netherlands). Fibrinogen was measured according to Clauss2 using thrombin from
DiaLab, Leusden, The Netherlands.
Routine clotting times, including the activated partial thromboplastin time
(aPTT), reflecting the intrinsic coagulation pathway and the prothrombin time
(PT), reflecting the extrinsic pathway, performed according to standard pro-
cedures. Reagents used were Actin, (Baxter Dade AG, Dtidingen, Switzerland)
for the aPTT and Thromborel-S, (Behring Diagnostica, Amsterdam, The
Netherlands) for the PT.
Statistics
Data were subjected to computerized statistical analysis (PATFILE statistical
package). Continuous variables are given as median (mean, + standard error of
the mean) and analyzed by nonparametric tests: in case of independent samples the
Mann-Whitney test was used, and in case of paired samples the Wilcoxon rank-sum
test. The coagulation changes were also analyzed in a multiple regression model
(SPSS/PC + ) using the three main variables in this study: the type of transplan-
tation, the use of PGE1 and the preservation time. The relative influence of these
variables on a coagulation parameter is represented by the T-value (ratio between
B and Standard Error of B) together with the significance of T.
RESULTS
Meaningful changes in hemostasis parameters during the operation are elaborated
on in the following paragraph. Data are presented separately for each of the threeLONG-TERM GRAFT PRESERVATION 269
main variables in this study: the type of transplantation, the effect of graft
preservation time, and the effect of PGE1.
Type of Transplantation
Fibrinolysis parameters: The changes in t-PA activity were reciprocal to those in
ECLT. During OLT, t-PA activity levels rose significantly during the anhepatic
period (p < 0.02), and increased sharply after reperfusion (p < 0.05) till the end of
the operation. In contrast, during HLT, t-PA activity levels remained low before
reperfusion, increased temporarily after reperfusion (p < 0.01) and normalized
again thereafter. The proportional increase in t-PA activity was similar in HLT and
OLT immediately after reperfusion. At all sampling points, except R-60 and R +
5, the t-PA activity in OLT was significantly higher than in HLT (at R-5" T -2.20,
p 0.03 and at R + 30 through R + 90: T between -2.79 and -3.12, p < 0.01).
The t-PA activity levels were higher in the first venous outflow of the graft (FR)
in HLT (1.22 IU/ml, median value) compared to OLT (0.36 IU/ml, p < 0.02),
while this difference was not yet present in the portal vein blood entering the graft
(T 1.06, p 0.32).
a2-AP levels declined significantly from R-60 through R + 5 (p < 0.001), and
remained almost unchanged thereafter, a2-AP levels were lower in OLT than in
HLT in the postreperfusion period from R + 30 through R + 90 (T between 2.08
and 3.37, p < 0.05).
Coagulation parameters: The PT and aPTT increased slightly in the period before
reperfusion and increased significantly thereafter (p < 0.001). Before reperfusion
and immediately thereafter, there was no significant difference between OLT and
HLT for these tests, but in the postreperfusion period, at R + 30 and R + 60, the
PT (T -3.48 and T -3.55, p 0.001) and aPTT (T -3.83 and T -4.11, p
< 0.001) were prolonged in OLT compared to HLT.
Fibrinogen levels practically halved before reperfusion (p < 0.001) without
reaching a significant difference between both types of transplantation (p 0.98).
After reperfusion, fibrinogen levels remained stable and at R + 5 and R + 30 the
fibrinogen level in OLT was significantly lower compared to HLT (T 2.05 and T
2.09, p < 0.05).
Graft Storage Time
Fibrinolysis parameters: The preservation time had an evident effect on the
fibrinolysis parameters, although not yet apparent at R + 5 (for t-PA: T 0.45, p
0.66). Especially at R + 60 and R + 90, the t-PA activity (Figure 1), the ECLT
and a2-AP deteriorated with increasing preservation times. The cold storage time
had some effect on t-PA activity and ECLT before reperfusion, although these did
not reach statistical significance in the multiple regression analysis (T 0.88, P
0.39 and T -0.86, p 0.39). The first venous outflow (FR) from the 2-hr and
24-hr preserved grafts contained high levels of t-PA activity. No increased t-PA
levels could be demonstrated in the first venous outflow from the 48-hr and 72-hr
preserved grafts.
Coagulation parameters: The multiple regression analysis for the effect of the
graft storage time revealed a clear influence on the PT and aPTT levels (Figures 2
and 3, respectively). This was evident in the period after reperfusion, starting at R270 C. MINKE BAKKER ET AL.
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+ 5 (T 2.38, P 0.02 and T 3.88, p < 0.001) and continuing till R + 30 for
PT (T 3.17, p < 0.01) and R + 60 for aPTT (T 3.93, p < 0.001).
In contrast, fibrinogen levels were not significantly influenced by graft storage
time. At R + 5 and R + 30 a longer ischemic period correlated with a decreased
fibrinogen level, but the difference was not significant.
The preservation time had an evident effect on the platelet count (all T-values
below-3.0 and p < 0.005).
<B > Use of PGE
Neither coagulation nor fibrinolysis tests were affected by PGE1 administration at
any of the measured points (data not shown).
Blood Loss and Suroioal
The amount of blood loss and blood transfusion in the different groups are given in
Table 3. In the multiple regression analysis blood loss was significantly controlled
by the type of transplantation (T -2.33, p 0.02) and the preservation time (T
2.88, p < 0.01). Because none of the animals survived OLT after 72 hr graft
storage, many never received a second unit of blood. This explains why it appeared
that HLT required more blood transfusion in the 72 hr experiment despite the
higher blood loss in OLT. In the multiple regression the duration of preservation
was a significant determinant of survival (T -3.59, p < 0.001). Survival was not
significantly different in the 2 hr preservation experiments. However, in the 24 hr
and 48 hr experiments, survival was significantly longer after HLT compared to
OLT (p < 0.05). Survival in the extended preservation experiments was dismal" In
OLT all animals died the day of the operation after 48 hr and 72 hr graft
preservation (three of which died within 30 minutes after reperfusion) and in HLT
all animals after 72 hr graft preservation. Three animals survived more than 3
weeks after HLT of a 24 hr preserved graft. Two more animals survived after HLT
for two days, one in the 24 hr group and one in the 48 hr group. In Table 4 the
causes of mortality are categorized.
Table 3 Median blood loss and blood transfusion during the transplantation
2 hr 24 hr 48 hr 72 hr
OLT HLT OLT HLT OLT HLT OLT HLT
Blood loss ml
--median 400 500 850 425 160 1125 1100 925
--lowest 250 250 400 100 700 600 200
--highest 1800 1200 2200 700 1500 2000 1500
Blood
Transfusion ml
--median
--lowest
--highest
650 600 1000 600 750 1100 600 1000
450 400 200 500 900 450 375
2000 1100 1200 1200 1250 1000 1500
aThe blood loss in the 2 hr experiment is lower compared to the longer preservation groups (p=0.03).
bSignificantly different from OLT.
COnly one animal represented.LONG-TERM GRAFT PRESERVATION 277
Table 4 Causes of death after liver transplantation
Total
2 hr 24 hr 48 hr
OLT HLT OLT HLT OLT HLT
16 15 8 8 2 5
72 hr
OLT HLT
6 9
Total
69
Hemorrhage 3 4 2
Portal vein block
Heart failure
Cholangitis 1
Volvulus 3 2
Rejection 2
Technical 4
Sacrificed 3 5
Others 2 2
Unknown 2 3 2
2 5
3
aTotal intrahepatic thrombosis of the portal venous system.
bOnly if rejection was thought to be the direct cause of death.
CPulmonary sepsis (n= 3), pneumothorax (n= 1), peritonitis (n= 1).
6 26
4
3
2
6
2
5
8
5
8
DISCUSSION
The results from this study clearly show that the host liver in HLT also protects the
recipient from the deleterious effects of long-term preserved grafts on hemostasis.
We found a dramatic and sustained increase in t-PA activity after reperfusion in
OLT, while the increase in t-PA in HLT was limited and transient. In OLT, the
deterioration of t-PA activity was directly related to the duration of graft storage.
In HLT this effect was much less evident, which demonstrated that the protective
effect of the host liver on the development of hyperfibrinolysis also holds true with
longer graft storage times. There are several explanations for the increase of t-PA
after reperfusion. First, endothelial cells, an important source of t-PA, are more
susceptible to cold hypoxia and reperfusion than parenchymal cells1’2. Free
oxygen radicals have been implicated in this mechanism of graft injury23’24. The
damaged endothelium may release t-PA directly into the circulation. Another
theory is that the tissue damage leads to the attraction of inflammatory cells,
including macrophages25’26. When activated, these cells are stimulated to produce
cytokines (interleukin-1, tumor necrosis factor), which may actively interfere with
coagulation and fibrinolysis27. Recently, it has been shown that pretreatment with
cyclosporine, a powerful inhibitor of the function of macrophages, ameliorated the
hemostatic changes after reperfusion in pigs, as measured by prothrombin times,
platelet counts, and fibrinogen levels8. The initial increase in t-PA activity in HLT
may be explained by a too abundant release of t-PA to be instantaneously cleared
by the host liver. Comparison of t-PA activity levels in the portal vein inflow and
the venous outflow revealed a gradient across the graft, which indicated that t-PA is
also actively released by the graft. It was found that t-PA levels in the first hepatic
outflow of the graft were higher in HLT than in OLT. A possible explanation is that
the partial resection of the liver graft in HLT is responsible for this. This extra
handling could make endothelial cells more liable to release t-PA9. It was notable
that the high t-PA activity levels were only found in the first hepatic outflow from278 C. MINKE BAKKER ET AL.
the 2 hr and 24 hr cold storage grafts and not in the 48 hr and 72 hr groups. Possibly,
the endothelial cells in the latter group are damaged to such an extent that they no
longer contain t-PA. Their contents, including t-PA, may have leaked into the
preservation fluid, which is subsequently washed out during flushing before reper-
fusion. Despite this t-PA depletion, subsequent contact activation of the blood with
the injured graft endothelium may evoke systemic t-PA release as suggested above.
Probably, the same process occurred in HLT, but now the cytokines may be cleared
by the host liver.
Fibrinogen levels, in turn, showed a serious decline in the prereperfusion period
in both OLT and HLT. There was no difference between OLT and HLT, which
suggests that the changes are related to the surgical procedure in general and not to
the anhepatic period. Previous investigators have suggested that fibrinogenolysis
during the use of an external bypass might also contribute to the decrease in
fibrinogen levels15’3. The latter is however likely to be of minor influence, as in
HLT no signs of hyperfibrinolysis were present nor was a shunt used. Although part
of the decline can be ascribed to hemodilution, there has to be another explanation
as the hematocrit, a measure of hemodilution, did not equally decrease. Most likely
a surgical induced activation of the coagulation system and extravasation of
hemostasis proteins to the extravascular space are involved29.
Similar to the fibrinolytic parameters, reperfusion induced a serious deterio-
ration in coagulation parameters in OLT, whereas the changes in HLT remained
limited. There was an apparent influence of the graft storage time. Presumably
release of procoagulant factors from the preserved graft or local clotting activation
on the damaged endothelium had initiated a consumption coagulopathy, as has
been previously described. The present observations, however, show that HLT has
also a protective effect on coagulation changes.
Remarkable effects of PGE1 were found in preventing warm ischemic and
reperfusion injury
31 in both experimental
32 and clinical1 studies. We therefore
implemented a trial of PGE1 in our experiment with long-term preservation. As
determined by fibrinolytic and coagulation tests, our study provides no evidence of
a protection against hemostatic disturbances. As opposed to the multitude of
positive studies on PGE1, it is difficult to explain why we found no protective effect
at all. Besides having included not enough animals to detect small differences,
there is probably only a narrow margin of therapeutic efficacy, if it exists, between
trivial and irreversible damage. Apparently, the upper limit is surpassed with 24 hr
preservation of the porcine liver. In addition, prostaglandins can be assumed to
counteract a physiological protective mechanism that secludes marginally function-
ing areas in the graft. This may well prove useful in retrieving reversibly injured
parenchyma
33 but in contrast, it could promote the entrance into the bloodstream
of deleterious substances originating from injured cells.
In conclusion, it was demonstrated that in pigs changes in hemostasis after long-
term graft storage are less dramatic in HLT compared to OLT. This suggests that
HLT also protects the recipient from the effects of long-term preserved grafts.
Addition of PGE1 to the preservation fluid had no effect on the hemostatic changes
in both OLT and HLT. Although these experiments are performed in the presence
of a healthy host liver (although deprived from portal blood after the transplan-
tation), while in the clinical situation the host liver is diseased, some remaining liver
function is always present. The results are indicative of the benificial role of the
(remnant function of the) host liver on hemostasis.LONG-TERM GRAFT PRESERVATION 279
Acknowledgements
The authors wish to thank the staff of the laboratory for surgical research for their
endurance and proficient assistance in these experiments. Ms A.M. Bijma is
gratefully acknowledged for the histocompatibility testing. We are indebted to Mr
W.J. Kooreman, The Upjohn Company, The Netherlands, for his kind gift of
prostaglandin E1 used in these studies.
References
1. Kang, Y.G., Martin, D.J., Marquez, J., Lewis, J.H., Bontempo, F.A., Shaw, B.W. Jr., Starzl,
T.E. and Winter, P.M. (1985) Intraoperative changes in blood coagulation and thrombelasto-
graphic monitoring in liver transplantation. Anesth. Analg., 64, 888-896
2. Von Kaulla, K.N., Kayne, H., Von Kaulla, E., Marchioro, T.L. and Starzl, T.E. (1966) Changes
in blood coagulation before and after hepatectomy or transplantation in dogs and man. Arch.
Surg., 92, 71-79
3. Blecher, T.E., Terblanche, J. and Peacock, J.H. (1968) Orthotopic liver homotransplantation.
Arch. Surg., 96, 331-339
4. B6hmig, H.J. (1977) The coagulation disorder of orthotopic hepatic transplantation. Semin.
Thromb. Hemostas., 4, 57-82
5. Porte, R.J., Bontempo, F.A., Knot, E.A.R., Lewis, H.J., Kang, Y.G. and Starzl, T.E. (1989)
Systemic effects of tissue plasminogen activator-associated fibrinolysis and its relation to thrombin
generation in orthotopic liver transplantation. Transplantation, 47, 978-984
6. Dzik, W.H., Arkin, C.F., Jenkins, R.L. and Stump, D.C. (1988) Fibrinolysis during liver
transplantation in humans: role of tissue-type plasminogen activator. Blood, 71, 1090-1095
7. Homatas, J., Wasantapruek, S., Von Kaulla, K.N. and Eiseman, B. (1969) Clotting abnormalities
following orthotopic and heterotopic transplantation of marginally preserved pig livers. Acta
Hepato-splenol., 2, 14-27
8. Mieny, C.J., Homatas, J., Moore, A.R. and Eiseman, B. (1968) Limiting functions of a preserved
liver homograft. Gastroenterology, 55, 179-182
9. Porte, R.J., Blankensteijn, J.D., Knot, E.A.R., de Maat, M.P.M., Groenland, ThN. and
Terpstra, O.T. (1991) A comparative study on changes in hemostasis in orthotopic and auxiliary
liver transplantation in pigs. Transplant Int., 4, 12-17
10. Gaber, A.O., Thistlethwaite, J.R. Jr., Busse-Henry, S., Aboushloe, M., Emond, J.C., Rouch, D.
and Broelsch, C.E. (1988) Improved results of preservation of hepatic grafts preflushed with
albumin and prostaglandins. Transplant Proc., 20, 992-993
11. Todo, S., Nery, J.R., Yanaga, K., Podesta, L., Gordon, R.D. and Starzl, T.E. (1989) Extended
preservation of human liver grafts with UW solution. JAMA, 261,711-714
12. Jamieson, N.V., Sundberg, R., Lindell, S., Claesson, K., Moen, J., Vreugdenhil, P.K. Wight,
D.G., Southard, J.H. and Belzer, F.O. (1988) Preservation of the canine liver for 24-48 hours
using simple cold storage with UW solution. Transplantation, 46, 517-522
13. Bijnen, A.B., Dekkers-Bijma, A.M., Vriesendorp, H.M. and Westbroek, D.L. (1979) Value of
the mixed lymphocyte reaction in dogs as a genetic assay. Immunogenetics, $, 287-297
14. Blankensteijn, J.D., Groenland, ThN., Baumgartner, D., Vos, L.P., Kerkhofs, L.G.M. and
Terpstra, O.T. (1990) Intraoperative hemodynamics in liver transplantation comparing orthotopic
with heterotopic transplantation in the pig. Transplantation, 49, 665-668
15. Denmark, S.W., Shaw, B.W. Griffith, B.P. and Starzl, T.E. (1983) Venous-venous bypass without
systemic anticoagulant in canine and human liver transplantation. Surg. Forum, 34, 380-382
16. Tobimatsu, M., Konomi, K., Saito, S. and Tsumagari, T. (1985) Protective effect of prostaglandin
E1 on ischemia induced acute renal failure in dogs. Surgery, 98, 45-52
17. Verheyen, J.H., Mullaart, E., Chang, G.T.G., Kluft, C. and Wijngaards, G. (1982) A simple,
spectrophotometric assay for the extrinsic (tissue-type) plasminogen activator applicable to
measurement in plasma. Thromb. Haemostas., 48,266-269
18. Kluft, C., Brakman, P. and Veldhuijzen-Stolk, E.C. (1976) Screening of fibrinolytic activity in
plasma euglobulin fractions on the fibrin plate. In: Davidson J.F., Samama, M.M., Desnoyers,
P.C., eds. Progress in chemical fibrinolysis and thrombolysis. New York: Raven Press, pp. 57-65
19. Friberger, P., Knos, M., Gustavsson, S., Aurell, L. and Claeson, G. (1978) Methods for the
determination of plasmin, antiplasmin and plasminogen by means of substrate S-2251.
Haemostasis, 7, 138-145280 C. MINKE BAKKER ET AL.
20. Clauss, A. (1957) Gerinnungsphysiologische Schnell Methode zur Bestimmung des Fibrinogens.
Acta Haematol. (Basel), 17, 237-246
21. Marzi, I., Zhong, Z., Lemasters, J.J. and Thurman, R.G. (1989) Evidence that graft survival is not
related to parenchymal cell viability in rat liver transplantation. The importance of nonparenchy-
mal cells. Transplantation, 48, 463-468
22. Caldwell-Kenkel, J.C., Currin, R.T., Tanaka, Y. Thurman, R.G. and Lemasters, J.J. (1989)
Reperfusion injury to endothelial cells following cold ischemic storage of rat livers. Hepatology,
10, 292-299
23. De Groot, H. and Brecht, M. (1991) Reoxygenation injury in rat hepatocytes mediation by
O2-/H202 liberated by sources other than xanthine oxidase. Biol. Chem. Hoppeseyler, 372, 35-41
24. Southard, J.H., Marsh, D.C., McAnulty, J.F. and Belzer, F.O. (1987) The importance of
Oz-derived free radical injury to organ preservation and transplantation. Transplant Proc., 19,
1380-1381
25. Takei, Y., Marzi, I., Kauffman, F.C., Currin, R.T., Lemasters, J.J. and Thurman, R.G. (1990)
Increase in survival time of liver transplants by protease inhibitors and a calcium channel blocker,
nisoldipine. Transplantation, 50, 14-20
26. Nolan, J.P. (1981) Endotoxin, reticuloendothelial function and liver injury. Hepatology, 1,458-
465
27. Nawroth, P.P., Handley, D. and Stern, D.M. (1986) The multiple levels of endothelial cell
coagulation factor interactions. In: Chesterman, C.N. (ed.) Clinics in Haematology, 293-321
28. Kim, Y.I., Kawano, K., Nakashima, K., Goto, S. and Kobayshi, M., (1991) Alleviation of 3.5
hour warm ischemic injury of the liver in pigs by cyclosporin pretherapy. Transplantation, 51,731-
733
29. Hickman, R., Bracher, M., Pienaar, B.H. and Terblanche, J. (1991) Heparin as the cause of
coagulopathy which may complicate grafting of the liver. Surg. Gynecol. Obstet., 172, 197-206
30. Rettke, S.R., Janossy, T.A., Chantigian, R.C., Burritt, M.F., Van Dyke, R.A., Harper, J.V.,
Ilstrup, D.M., Taswell, H.F., Wiesner, R.H. and Krom, R.A.F. (1989) Hemodynamic and
metabolic changes in hepatic transplantation. Mayo Clin. Proc., 64, 232-240
31. Ueda, Y., Matsuo, K., Kamei, T., Kayashima, K. and Konomi, K. (1989) Protective effect of
prostaglandin E1 (PGE) on energy metabolism and reticuloendothelial function in the ischemi-
cally damaged canine liver. Lioer, 9, 6-13
32. Ueda, Y., Matsuo, K., Kamei, T., Ono, H., Kayashima, K., Tobimatsu, M. and Konomi, K.
(1987) Prostaglandin E1 but not Ez is cytoprotective of energy metabolism and reticuloendothelial
function in the ischemic canine liver. Transplant Proc., 19, 1329-1330
33. Greig, P.D., Woolf, G.M., Sinclair, S.B., Abecassis, M., Strasberg, S.M., Taylor, B.R., Blendis,
L.M., Superina, R.A. Glynn, M.F.X., Langer, B. and Levy, G.A. (1989) Treatment of primary
liver graft nonfunction with prostaglandin El. Transplantation, 48 447-453
(Accepted by S. Bengmark 23 April 1993)